Kyndryl begins its evolution

In November 2021, IBM completed the separation of Kyndryl, which listed on the NYSE. The separation is good for both parties. IBM’s first set of quarterly results since the split show that - not surprisingly - without Kyndryl on the books, its top line is a lot healthier. And while Kyndryl has been spun-off, a very significant commercial relationship remains between the two.

As a separate entity, Kyndryl is now free to pursue new partnerships and market opportunities. It can steer investments to support its own specific strategy and reinvigorate staff with new strategic goals and opportunities. Work to evolve the firm has already very much begun as Kyndryl begins it next chapter. This report looks at some of the actions taken.

Ways to access this research

« Back to previous page